Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 925 of 5804
-
New hope for kids with tough cancers: targeted drug attacks gene flaw
Disease control OngoingThis phase II Pediatric MATCH trial studies how well ulixertinib works in treating patients with solid tumors that have spread to other places in the body (advanced), non-Hodgkin lymphoma, or histiocytic disorders that have a genetic alteration (mutation) in a signaling pathway c…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope: immune drug may replace chemo for rare nasal lymphoma
Disease control OngoingThe purpose of this study is to test how well pembrolizumab shrinks Early-Stage NK/T-cell Lymphoma (ENKTL) in participants who have not yet received chemotherapy.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Newborn screening study aims to catch rare diseases at birth
Diagnosis OngoingEarly Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approach to identify affected infants, 2) address the impact on infants and families who screen positive, and 3) evaluate the …
Sponsor: RTI International • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
Could umbilical cord stem cells ease knee arthritis pain?
Disease control Recruiting nowThe purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Osteoarthritis, and in addition, provide basis for exploring the treatment regimen of UC-MSC therapy in different degree of cartilage defe…
Phase: PHASE2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Sound waves vs. prostate cancer: new study tracks Real-World results
Disease control Recruiting nowThe Sonablate HIFU device was approved by the U.S.FDA for prostate tissue ablation in October, 2015. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using HIFU through clinical data and health-related quality of life (…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Eye implant could reduce need for frequent shots for blinding disease
Disease control Recruiting nowThis study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR4054…
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New heart procedure aims to stop persistent AFib without pills
Disease control CompletedThe purpose of the Diamond-AF II study is to establish the safety and effectiveness of the DiamondTemp Ablation System for the treatment of drug refractory, symptomatic persistent atrial fibrillation in patients.
Phase: NA • Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Saline vs. Ringer's: which fluid saves more lives in septic shock?
Disease control CompletedDespite evidence of the physiologic benefits and possible lower mortality associated with low chloride solutions, normal saline remains the most wildly used fluid in the world. Given uncertainty about the impact of lower chloride versus higher chloride solutions on mortality, it …
Phase: PHASE2, PHASE3 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Psoriasis drug bimekizumab shows promise in Long-Term safety trial
Disease control CompletedThis is a study to evaluate the long-term safety and tolerability of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis (PSO).
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a daily aspirin protect diabetic Moms-to-Be?
Disease control CompletedTo investigate the effect of aspirin therapy initiated in the first trimester of pregnancy in women with pregestational type I or type II diabetes on a composite clinical measure of placental dysfunction (preeclampsia, preterm birth less than 34 weeks, birthweight below the 10th …
Phase: PHASE3 • Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New study seeks to sharpen Alzheimer's diagnosis with simple tests
Diagnosis Recruiting nowThe participant in this study includes Alzheimer's disease (AD including familial AD and sporadic AD) patients, amnestic mild cognitive impairment (aMCI) patients, non-AD dementia patients and cognitively normal control. The purpose of this study is to establish the best cut-off…
Sponsor: Capital Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC
-
Dissolvable heart patch offers hope for kids with hole in the heart
Disease control CompletedThe aim of this study is to evaluate the safety and efficacy of Absnow absorbable ASD closure system for treating patients with atrial septal defect.
Phase: NA • Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a common cholesterol drug shrink uterine fibroids?
Disease control OngoingThe study aims to study the effect of simvastatin on the size of uterine fibroids.
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New pill may keep yeast infections away for good
Disease control CompletedRecurrent vulvovaginal candidiasis (RVVC), also known as recurrent yeast infections, is defined as at least 3 episodes of acute VVC in the past 12 months. Several properties of oteseconazole (VT-1161) suggest that it might be a safer and more effective treatment for RVVC than oth…
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Yeast vaccine shows promise in stopping Cancer's return
Disease control CompletedThis is a phase 1 study to evaluate the safety, the Recommended Phase 2 Dose (RP2D), and preliminary efficacy of a personalized neoepitope yeast-based vaccine, YE-NEO-001, in subjects who have completed potentially curative therapy for their solid cancer and who would otherwise b…
Phase: PHASE1 • Sponsor: NantBioScience, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Engineered immune cells take on kidney cancer in early trial
Disease control OngoingBackground: Gene transfer is a new cancer therapy takes white blood cells from a person and grows them in a lab. The cells are changed with a virus to attack tumor cells, then returned to the person. Researchers want to see if this therapy fights kidney cancer cells. Objective:…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Shorter radiation after breast surgery shows promise for cancer control
Disease control OngoingThis study is to evaluate the efficacy and toxicity of accelerated partial breast irradiation (ABPI) with intensity modulated radiation therapy (IMRT) in low-risk breast cancer treat with breast-conserving surgery.
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Rectal cancer: could a 'Watch and Wait' strategy spare patients from major surgery?
Disease control TerminatedThe purpose of this project is to determine if in a selected group of patients, at higher risk of wound dehiscence and other complications, treatment by local excision and management by a "watchful waiting" or an initial "non-operative management" approach, with an offer of radic…
Phase: NA • Sponsor: Henry Ford Health System • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a vaccine prevent genital warts from returning after surgery?
Disease control CompletedLarge genital warts are frequently diagnosed in general gynaecology and oncology clinics in South Africa. Medical and destructive therapy for small warts is generally very effective, however unique problems posed by large or extensive genital warts are not so easily solved and tr…
Phase: PHASE3 • Sponsor: University of Pretoria • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New Catheter-Based valve repair could help heart patients avoid surgery
Disease control OngoingClinical Study of the Edwards Cardioband FIT Repair System
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC